ROS

Double-edged sword for leukemic cells

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

There is increasing evidence that chemotherapeutic drugs can work via acceleration of reactive oxygen species in human malignancy.

Original languageEnglish (US)
Pages (from-to)2212-2213
Number of pages2
JournalBlood
Volume107
Issue number6
DOIs
StatePublished - Mar 15 2006

Fingerprint

Reactive Oxygen Species
Pharmaceutical Preparations
Neoplasms

ASJC Scopus subject areas

  • Hematology

Cite this

ROS : Double-edged sword for leukemic cells. / Kay, Neil Elliot.

In: Blood, Vol. 107, No. 6, 15.03.2006, p. 2212-2213.

Research output: Contribution to journalArticle

Kay, Neil Elliot. / ROS : Double-edged sword for leukemic cells. In: Blood. 2006 ; Vol. 107, No. 6. pp. 2212-2213.
@article{815f78f469ce426e8fd713002c5ca129,
title = "ROS: Double-edged sword for leukemic cells",
abstract = "There is increasing evidence that chemotherapeutic drugs can work via acceleration of reactive oxygen species in human malignancy.",
author = "Kay, {Neil Elliot}",
year = "2006",
month = "3",
day = "15",
doi = "10.1182/blood-2005-12-5174",
language = "English (US)",
volume = "107",
pages = "2212--2213",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "6",

}

TY - JOUR

T1 - ROS

T2 - Double-edged sword for leukemic cells

AU - Kay, Neil Elliot

PY - 2006/3/15

Y1 - 2006/3/15

N2 - There is increasing evidence that chemotherapeutic drugs can work via acceleration of reactive oxygen species in human malignancy.

AB - There is increasing evidence that chemotherapeutic drugs can work via acceleration of reactive oxygen species in human malignancy.

UR - http://www.scopus.com/inward/record.url?scp=33644755521&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644755521&partnerID=8YFLogxK

U2 - 10.1182/blood-2005-12-5174

DO - 10.1182/blood-2005-12-5174

M3 - Article

VL - 107

SP - 2212

EP - 2213

JO - Blood

JF - Blood

SN - 0006-4971

IS - 6

ER -